Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001181431-13-026211

Options or other derivatives

  • Chief Operating Officer acquired 170,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

GIVEN BRUCE D · Chief Operating Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2013-05-06 Grant or award : show line 1 in the form Stock Option +170,000 346,000 D
Loading xslF345X03/rrd378786.xml…